An Engineered Split-TET2 Enzyme for Chemical-inducible DNA Hydroxymethylation and Epigenetic Remodeling
December 18th, 2017
6.2K views
Detailed protocols for introducing an engineered split-TET2 enzyme (CiDER) into mammalian cells for chemical inducible DNA hydroxymethylation and epigenetic remodeling are presented.
Overview
This article presents detailed protocols for introducing an engineered split-TET2 enzyme, CiDER, into mammalian cells. This method facilitates chemical inducible DNA hydroxymethylation and epigenetic remodeling.
Key Study Components
Area of Science
- Epigenetics
- Cell Biology
- Molecular Biology
Background
- Understanding DNA modification is crucial for epigenetic research.
- 5-methylcytosine oxidation plays a significant role in gene regulation.
- Temporal control of epigenetic states can enhance experimental precision.
- CiDER offers a novel approach to study these modifications.
Purpose of Study
- To introduce CiDER for inducible DNA hydroxymethylation.
- To explore its potential in epigenetic remodeling.
- To provide a reliable method for temporal control of DNA modifications.
Methods Used
- Culturing adherent cell lines in DMEM with supplements.
- Transfecting cells with the CiDER plasmid.
- Incubating cells under specific conditions for optimal results.
- Utilizing chemical additives for inducing modifications.
Main Results
- Successful introduction of CiDER into mammalian cells.
- Demonstrated control over DNA hydroxymethylation.
- Facilitated epigenetic remodeling in response to chemical inducers.
- Provided insights into the dynamics of epigenetic changes.
Conclusions
- CiDER is a valuable tool for studying DNA modifications.
- This method enhances our understanding of epigenetic regulation.
- Future applications may lead to breakthroughs in gene therapy.
Frequently Asked Questions
What is the CiDER enzyme?
CiDER is an engineered split-TET2 enzyme used for inducible DNA hydroxymethylation.
How does the CiDER method work?
It allows temporal control of DNA modifications using chemical inducers.
What cell lines can be used with this protocol?
Adherent cell lines cultured in DMEM are suitable for this method.
What are the advantages of using CiDER?
It provides precise control over epigenetic states and DNA modifications.
Can this method be applied to other types of cells?
While designed for mammalian cells, adaptations may allow broader applications.
What are the implications of this research?
It may lead to advancements in understanding epigenetics and gene therapy.
Executive Industry Relevance
Precise temporal control of epigenetic modifications enables mechanistic de-risking in target validation by establishing causal links between DNA hydroxymethylation and phenotypic outcomes. The CiDER system supports predictive confidence in epigenetic drug discovery by allowing reversible, dose-dependent remodeling without genetic alteration. This capability addresses a critical gap in probing epigenotype-phenotype relationships in disease-relevant systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by inducing site-specific 5hmC production to assess downstream gene expression changes.
- Operational Value: Provides a chemical-inducible system for temporal control, reducing variability in epigenetic endpoint measurements.
- Predictive Value: Supports mechanistic de-risking of epigenetic targets by correlating inducible 5hmC levels with functional readouts in mammalian cells.
Screening & Assay Development
- Assay Readiness: Generates quantifiable 5hmC outputs via immunostaining, flow cytometry, or dot-blot for high-content screening applications.
- Reproducibility: Enables standardized induction with rapamycin, allowing consistent epigenetic remodeling across replicates and cell lines.
- Scalability: Compatible with flow cytometry and dot-blot formats, supporting medium-throughput epigenetic profiling in drug discovery workflows.
Translational & Preclinical Research
- Disease Relevance: Facilitates probing of epigenotype-phenotype relations in biological systems where TET2 dysregulation is implicated, such as oncology and developmental disorders.
- Translational Continuity: Supports progression from discovery to preclinical validation by enabling reversible epigenetic modulation in mammalian models.
- Risk-Adjusted Advancement: Allows assessment of epigenetic remodeling effects prior to committing to target-specific inhibitor development.
Pipeline & Workflow Integration
The CiDER method integrates into early discovery workflows by providing a controllable epigenetic modulation tool that bridges target validation and assay development stages.
- Discovery Biology: Supports hypothesis testing through inducible 5hmC generation, enabling causal inference in epigenetic regulatory networks.
- Screening: Delivers quantitative 5hmC readouts via flow cytometry and dot-blot, facilitating compound effect assessment on epigenetic states.
- Analytics: Provides measurable outputs (5hmC levels) that allow comparison of induced versus baseline conditions for target engagement evaluation.
- Translational Research: Enables preclinical continuity by modeling epigenetic remodeling in mammalian cells relevant to human disease pathways.
- Enterprise Reuse: Functions as a reusable platform for epigenetic modulation across multiple targets and cell lines without genetic engineering of endogenous loci.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking of epigenetic targets through precise, reversible control of DNA hydroxymethylation.
- Operational Value: Standardized induction via rapamycin enables reproducible epigenetic remodeling across experimental batches.
- Strategic Value: Improves go/no-go decisions by reducing ambiguity in epigenetic mechanism-of-action studies.
- Portfolio Impact: Supports risk-adjusted prioritization of epigenetic targets by validating functional consequences of 5hmC induction.
Implementation Considerations
- Requires expertise in mammalian cell culture, transfection, and epigenetic assay techniques.
- Dependent on fluorescence-activated cell sorting or dot-blot instrumentation for 5hmC quantification.
- Necessitates standardization of rapamycin dosing and incubation times for consistent induction across teams.
- Adaptation considerations include varying transfection efficiencies and endogenous TET expression levels across cell models.
- Practical limitations include potential off-target effects of rapamycin and the need for proper controls to distinguish CiDER-specific activity.
Biopharma FAQs
Why does inducible 5hmC production matter for target validation?
Inducible 5hmC production allows researchers to establish causal relationships between epigenetic modifications and gene expression changes, which is critical for validating epigenetic targets in drug discovery.
How does chemical induction of TET2 activity fit into the discovery pipeline?
Chemical induction enables temporal control of DNA hydroxymethylation, allowing precise timing of epigenetic modulation during target validation and mechanistic studies.
What quantitative measurements of 5hmC enable epigenetic screening?
Flow cytometry and dot-blot assays provide quantifiable 5hmC readouts that support high-content screening and compound effect assessment on epigenetic states.
Why are replication requirements important for epigenetic remodeling studies?
Replication ensures consistent inducible 5hmC levels across experiments, which is essential for reliable cross-functional collaboration and data interpretation in target validation.
What statistical analysis is needed before implementing inducible epigenome remodeling?
Statistical comparison of 5hmC levels between induced and control conditions is required to determine significant epigenetic changes and support target engagement conclusions.
Chapters in this video
0:05
Title
0:48
Cell Culture, Plasmid Transfection, and Chemical Induction
1:45
Quantification of Rapamycin-indiced 5-hydroxymethylcystosine (5hmc) Production by Immunostaining
3:08
Dot-blot Assay Quantify 5hmc and 5-methylcystosine (5mc) Amounts
7:03
Results: Validation of Chemically Induced 5hmc Levels
7:58
Conclusion
